Switzerland

Back to Search

International Partner Search

Innovation & Technology Offer

Innovative and accurate drug delivery systems suited for injections in the dermal layer of the skin.

Country of Origin: Belgium
Reference Number: TOBE20170825001
Publication Date: 16 July 2019

Summary

A Belgian SME has developed an accurate drug delivery system in therapeutic fields such as: treatment of infectious diseases, cell therapy for genetic diseases, intradermal allergy testing and anti-inflammatory injections in skin diseases. Currently in prototyping phase. After a successful Proof-of-Concept study using a HepB Vaccine, now preparing for CE-marking and FDA registration. They are looking for partnerships with Pharma & Biotech companies & research institutes.

Description

Belgian based company produces a device that consists of injection moulded parts (medical grade plastics) and a stainless-steel needle which is manufactured in Japan. Assembly, packaging and batch release of fully finished end-product is done at the Headquarters  in Belgium.
A platform of variants is being prepared depending on needle characteristics (length – thickness) and a prefilled/non-prefilled/ lyophilized two-chamber variant. By varying the thickness, actual cells as therapeutic agents can be included. Depending on the variant it can be used in different clinical therapeutic areas.

This can lead to a broader possible commercial market, not only human but also veterinary applications.
Targeted therapeutic areas: treatment of infectious diseases (e.g. polio), cell therapy for genetic diseases like MS, intradermal allergy testing and anti-inflammatory injections in skin diseases
They are actively looking for pharma and biotech companies that are looking for solutions to deliver their drugs intradermally. Similarly, we are seeking collaboration with research institutes to enable interaction and partnerships.
Image

Image

Advantages and Innovations

The company is a leader in user-friendly and game-changing medical device solutions for drugs delivery systems in the skin with a unique design, that improve accuracy and standardization while making handling easier, more consistent and more comfortable for the user. The company is linked to a University, endorsed on multiple occasions nationally and internationally for its solutions.
The medical device with an original design is a delivery device suited for standardized and guaranteed delivery of small volumes of drugs (i.e. vaccine). The device is designed in such a way that it is easy to use (perpendicular on the skin, one click method).

Stage Of Development

Prototype available for demonstration

Stage Of Development Comment

The product is in late stages of development. First partnerships have been formed in Japan through which the product is being evaluated in preclinical research.

Requested partner

The Belgian company is actively seeking partnerships and collaborations with pharma and biotech companies as well as R&D organisations that are  in need for an accurate drug delivery system targeting the dermal layer of the skin.
We are looking for distribution and commercial potential partnerships.

Cooperation offer is closed for requests